Reducing Cardiovascular Risk in Type 2 Diabetes: What I Do and Why

Learn strategies to reduce cardiovascular risk in your patients with T2DM. Hear from a leading endocrinologist, cardiologist, and primary care clinician as they discuss how they would manage a series of patients highlighting the spectrum of cardiovascular risk.
Zachary T. Bloomgarden, MD, MACE
Program Director
Mikhail N. Kosiborod, MD
Kushner_Pamela_32x32
Pamela Kushner, MD, FAAFP

Downloadable Slideset

Download these slides to learn how leading experts approach a series of patients that cover the spectrum of CV risk in diabetes.

Zachary T. Bloomgarden, MD, MACE
Program Director
Mikhail N. Kosiborod, MD Kushner_Pamela_32x32 Pamela Kushner, MD, FAAFP
Released: June 29, 2018

Video Module

Listen as a multidisciplinary expert panel debates optimal management of patients with T2DM and varying degrees of cardiovascular risk.

Zachary T. Bloomgarden, MD, MACE
Program Director
Mikhail N. Kosiborod, MD Kushner_Pamela_32x32 Pamela Kushner, MD, FAAFP
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: July 20, 2018 Expired: No longer available for credit
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by an educational grant from
Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue